未找到相关数据
Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.
被引：1
作者：
Saad, Eddy
Labaki, Chris
Miron, Benjamin
Park, Jihye
Bakouny, Ziad
Nassar, Amin
Saliby, Renee Maria
Semaan, Karl
Eid, Marc
Meli, Kevin
Laimon, Yasmin Nabil
Geynisman, Daniel M.
Kokate, Rutika
Braun, David A.
Signoretti, Sabina
Mcgregor, Bradley Alexander
Plimack, Elizabeth R.
Choueiri, Toni K.
Van Allen, Eliezer Mendel
Zibelman, Matthew R.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Fox Chase Canc Ctr, Philadelphia, PA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Harvard Univ, Cambridge, MA USA
[7] Brigham & Womens Hosp, Boston, MA USA
[8] Yale Univ, New Haven, CT USA
[9] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[10] Fox Chase Canc Ctr, Temple Hlth, Philadelphia, PA USA
[11] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
关键词：
283-2494-9200;
3282-206-3691-5663-4986;
613-225-3248-9559-9794;
3282-206-3691-2722-5055;
3282-646-4685-2628;
5;
3;
2;
38092-18323;
38092-27449;
38092-23384;
D O I：
10.1200/JCO.2024.42.4_suppl.459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文